You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Antiviral Therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nirmatrelvir-ritonavir in Hospitalized Patients

Recruiting
  • Hospitalized Patients
  • Hangzhou, Zhejiang, China
    Changcheng Shi
Feb 26, 2023

Predict Antiviral Therapy in Gray Zone of Chronic Hepatitis B

Not yet recruiting
  • Hepatitis B, Chronic
  • Exposure factors
  • (no location specified)
Sep 10, 2023

COVID-19 Infection and Its Clinical Prognosis in Chronic

Recruiting
  • Chronic Hepatitis B
  • COVID-19 Infection
  • Beijing, Beijing, China
    Department of Hepatology Division 2, Beijing Ditan Hospital
Mar 28, 2023

COVID-19, Immunodeficiency Trial (Paxlovid 5 days, Paxlovid 10 days, Tixagevimab and Cilgavimab)

Not yet recruiting
  • COVID-19
  • Immunodeficiency
  • Paxlovid 5 days
  • +2 more
  • (no location specified)
Oct 18, 2022

Covid19 Trial in Niagara, Toronto, Montreal (Omalizumab, Placebo)

Active, not recruiting
  • Covid19
  • Omalizumab
  • Placebo
  • Niagara, Ontario, Canada
  • +2 more
Nov 14, 2022

Liver Cancer Trial in Houston (Bevacizumab, Atezolizumab, Sofosbuvir)

Not yet recruiting
  • Liver Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Feb 9, 2023

Effects of Antiviral Therapy on Patients With HBV-related HCC

Completed
  • Hepatocellular Carcinoma
  • +2 more
  • Medication history
  • (no location specified)
Jun 17, 2022

Viral Hepatitis D Relapses Upon Discontinuation of Bulevertide

Recruiting
  • Chronic Hepatitis D
    • Moscow, Russian Federation
      Center of Target Therapy
    Nov 6, 2023

    Hepatitis B Virus Infection Trial in Changsha (Standard antiviral therapy)

    Recruiting
    • Hepatitis B Virus Infection
    • Standard antiviral therapy
    • Changsha, Hunan, China
      Department of Infectious Disease, Xiangya Hospital, Central Sout
    May 22, 2022

    Antiviral Therapy for Patients With Liver Cancer After Surgery

    Recruiting
    • Hepatocellular Carcinoma
      • Changsha, Hunan, China
        Xiangya Hospital of Central South University
      Jul 19, 2022

      Hepatitis B Virus Trial in Puerto Rico, United States (Cemiplimab)

      Suspended
      • Hepatitis B Virus
      • Cemiplimab
      • Los Angeles, California
      • +6 more
      Dec 5, 2022

      Hepatitis B, Chronic Trial in Gothenburg (Stopping)

      Not yet recruiting
      • Hepatitis B, Chronic
      • Stopping
      • Gothenburg, VGR, Sweden
        Infectious Diseases Clinic, Sahlgrenska University Hospital
      Apr 13, 2022

      AIDS Virus, Disorder of Immune Reconstitution Trial in Jinan (normal saline, Mesenchymal stem cells)

      Recruiting
      • AIDS Virus
      • Disorder of Immune Reconstitution
      • normal saline
      • Mesenchymal stem cells
      • Jinan, Shandong, China
        Shandong Public Health Clinical Center
      May 14, 2023

      COVID-19 Trial in London (Favipiravir, Lopinavir/ Ritonavir, Favipiravir Placebo)

      Completed
      • COVID-19
      • London, United Kingdom
      • +1 more
      Dec 12, 2022

      Chronic Hepatitis B Virus Infection Trial in Guangzhou (Entecavir, Entecavir combined with Tenofovir Amibufenamide)

      Recruiting
      • Chronic Hepatitis B Virus Infection
      • Entecavir
      • Entecavir combined with Tenofovir Amibufenamide
      • Guangzhou, Guangdong, China
        The Third Affiliated Hospital of Sun Yat-sen University
      May 15, 2022

      Chronic Hepatitis c Trial in Assiut (lipid profile, fasting insulin, fibro scan)

      Recruiting
      • Chronic Hepatitis c
      • lipid profile
      • +2 more
      • Assiut, Egypt
        Assiut University hospital
      Feb 23, 2022

      COVID-19 Trial in Mansoura (Casirivimab and Imdevimab Drug Combination, Remdesivir, Favipiravir)

      Completed
      • COVID-19
      • Casirivimab and Imdevimab Drug Combination
      • +2 more
      • Mansoura, El-dkhalia, Egypt
        El-gomhoria St
      Aug 13, 2022

      HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated

      Not yet recruiting
      • HBV
      • HCC
      • nucleoside analogues or interferon
      • Hefei, Anhui, China
      • +9 more
      Jul 20, 2023

      COVID-19 Trial in Chengdu (VV116+SOC, SOC)

      Recruiting
      • COVID-19
      • Chengdu, Sichuan, China
        Chengdu Zenitar Biomedical Technology Co., Ltd
      Feb 3, 2023

      Chronic Hepatitis b Trial in Beijing, Chongqing (STSG-0002 Injection)

      Not yet recruiting
      • Chronic Hepatitis b
      • STSG-0002 Injection
      • Beijing, Beijing, China
      • +3 more
      Mar 6, 2023

      Chronic Hepatitis b Trial in Beijing, Chongqing (STSG-0002 Injection)

      Not yet recruiting
      • Chronic Hepatitis b
      • STSG-0002 Injection
      • Beijing, Beijing, China
      • +3 more
      Mar 6, 2023

      Chronic Hepatitis B Trial in Seoul (Standard of care)

      Active, not recruiting
      • Chronic Hepatitis B
      • Standard of care
      • Seoul, Korea, Republic of
      • +3 more
      Mar 29, 2023

      Diabetes, Hepatitis C, Chronic, Cardiovascular Diseases Trial run by the National Institute of Diabetes and Digestive and Kidney

      Recruiting
      • Diabetes Mellitus
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 27, 2023

      Sars-CoV2, Covid-19 Trial in Brazil, Canada (Peginterferon Lambda-1A, )

      Recruiting
      • Sars-CoV2
      • Covid-19
      • Peginterferon Lambda-1A
      • placebo
      • Botucatu, Brazil
      • +6 more
      Jan 17, 2022

      After Long-Term Antiviral Treatment for Chronic Hepatitis B

      Completed
      • Chronic Hepatitis B e Antigen Positive
      • Chronic Hepatitis B e Antigen Negative
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 26, 2023